Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Clinical trial NCT04395092 · WITHDRAWN

Trial details

NCT number: NCT04395092
Sponsor: Kiadis Pharma
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)

Start date: 2020-11-13
Primary completion: 2022-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.